Harbor View Cancer Center

Baltimore, Maryland 21225

0 studies enrolling now · 3 studies all time

What they study most

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Metastatic Non-small Cell Lung Cancer, NSCLC, Neoplasm Metastasis, Non-small Cell Lung Cancer

Studies at this site

• Study of Carboplatin/Paclitaxel With or Without Investigational Drug (CS-7017) in Subjects With Metastatic Non-small Cell Lung Cancer — Completed
• Weekly vs. Every 2 Week vs. Every 3 Week Administration of ABI-007 (Abraxane)/Bevacizumab Combination in Metastatic Breast Cancer — Stopped early
• Erlotinib or Placebo Following Chemoradiotherapy (Chemo/RT) in Stage III Non-Small Cell Lung Cancer (NSCLC) — Completed